Squamous carcinoma is the most common type of lung cancer, and the survival period of patients at different stages is different. Early stage patients have a relatively long survival period and may be cured, while late stage patients generally have a shorter survival period and can only prolong their lives through treatment. Squamous carcinoma is a common type of lung cancer and the survival period is different for each patient. The survival of patients is not only related to the extent of the disease, but also closely related to the physical quality of the patient and the effect of the later treatment. For early stage cancer patients, as long as they are treated actively, many patients can be cured. For advanced stage patients, due to their critical condition, they can only try to control their disease, relieve their pain and prolong their lives as much as possible. The survival period of early stage patients is generally longer, with a five-year survival rate of 70 to 80 percent. For patients with advanced disease, the survival period is generally shorter, with a five-year survival rate of less than 30%. Survival is completely different for patients with different conditions, and even for the same patients, survival varies greatly, with great individual differences. Therefore, it is meaningless to predict survival with just a diagnosis of the disease, without knowing the physical condition of the patient, the severity of the disease, and how effective the treatment will be.